Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nandagopal Paneerselvam

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Immunology (Orlando, Fla.)|August 23, 2023
Antiretrovirals to CCR5 CRISPR/Cas9 gene editing - A paradigm shift chasing an HIV cureAmber Khan, Nandagopal Paneerselvam, Brian R Lawson
Clinical Immunology (Orlando, Fla.)|October 18, 2023
Broadly neutralizing antibodies targeting HIV: Progress and challengesNandagopal Paneerselvam, Amber Khan, Brian R Lawson
The Lancet. HIV|July 31, 2021
Temporal change in population-level prevalence of detectable HIV viraemia and its association with HIV incidence in key populations in India: a serial cross-sectional studyEshan U Patel, Sunil S Solomon, Gregory M Lucas, et al.
The Lancet. HIV|April 7, 2024
Voucher incentives to improve viral suppression among HIV-positive people who inject drugs and men who have sex with men in India: a cluster randomised trialSunil S Solomon, Allison M McFall, Aylur K Srikrishnan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Immunology (Orlando, Fla.)|August 23, 2023
Antiretrovirals to CCR5 CRISPR/Cas9 gene editing - A paradigm shift chasing an HIV cureAmber Khan, Nandagopal Paneerselvam, Brian R Lawson
Clinical Immunology (Orlando, Fla.)|October 18, 2023
Broadly neutralizing antibodies targeting HIV: Progress and challengesNandagopal Paneerselvam, Amber Khan, Brian R Lawson
The Lancet. HIV|July 31, 2021
Temporal change in population-level prevalence of detectable HIV viraemia and its association with HIV incidence in key populations in India: a serial cross-sectional studyEshan U Patel, Sunil S Solomon, Gregory M Lucas, et al.
The Lancet. HIV|April 7, 2024
Voucher incentives to improve viral suppression among HIV-positive people who inject drugs and men who have sex with men in India: a cluster randomised trialSunil S Solomon, Allison M McFall, Aylur K Srikrishnan, et al.
Pageof 1